« Return to News | CROs/Service Providers

ICON reports quarterly revenue up 5%

Friday, February 17, 2012 01:43 PM

ICON, a global CRO, has reported financial results for the full year and for the fourth quarter ending Dec. 31, 2011.

For the fourth quarter, net revenues grew 5% year on year to $242.6 million and operating income was $6.6 million, representing 3% of revenue, compared to $22 million or 9% for the year-ago quarter. Net income was $4.1 million compared with $22.1 million last year, or $0.07 per share compared to $0.36 in the year-ago quarter.

For the full year 2011, revenue grew 5.1% to $946 million and operating income before non-recurring charges was $39.3 million, representing 4.2% of revenue, compared to $92 million or 10.2% in 2010. On a U.S. GAAP basis, income from operations was $29.4 million, compared with $92 million in the prior year.

Net income before non-recurring charges was $31.5 million, a net margin of 3.3%, compared to $87.1 million and 9.7% of revenue a year ago. EPS before non-recurring charges for 2011 was $0.52 per share, compared with $1.44 in 2010. On a U.S. GAAP basis, net income was $22.8 million, a net margin of 2.4%, compared to $87.1 million and 9.7% of revenue a year ago. EPS on a GAAP basis for 2011 was $0.37 per share compared with $1.44 in 2010.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.